[The correction of hyperuricemia in patients with different forms of nephrolithiasis using allopurinol and Allomaron].

Abstract

Metabolic status was assessed in 48 patients with nephrolithiasis followed-up for 4 years. Allopurinol and allomaron-treated patients were examined biochemically by 17 parameters of the blood and urine. The effects of the drugs were compared. It is concluded that in hyperuricemia up to 0.37 +/- 0.02 mmol/l allomaron is more effective (1--2 pills a day). In higher hyperuricemia allopurinol is preferable (4 pills a day). Allomaron can be also used (1--2 pills a day) under the control of urinalysis.

• Authors: A F Darenkov, O V Konstantinova, E K Ianenko
• Journal: Urologiia i nefrologiia (Urol Nefrol (Mosk)) 1994 Sep-Oct Issue 5 Pg. 35-7 ISSN: 0042-1154 [Print] Russia (Federation)
• Vernacular Title: Korrektsiia giperurikemii u bol'nykh s razlichnymi formami nefrolitiaza allopurinolom i allomaronom.
• PMID: 7871619 (Publication Type: Comparative Study, English Abstract, Journal Article)

Chemical References

• Drug Combinations
• Tablets
• allopurinol, benzbromarone drug combination
• Uric Acid
• Benzbromarone
• Allopurinol

Topics

• Adult
• Aged
• Allopurinol (therapeutic use)
• Benzbromarone (therapeutic use)
• Drug Combinations
• Drug Evaluation
• Female
• Humans
• Kidney Calculi (complications, drug therapy, metabolism)
• Male
• Middle Aged
• Recurrence
• Tablets
• Uric Acid (blood)